Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-24-030001
Filing Date
2024-12-20
Accepted
2024-12-20 20:30:02
Documents
1
Period of Report
2024-12-10

Document Format Files

Seq Description Document Type Size
1 form4-12212024_011259.html 4  
1 form4-12212024_011259.xml 4 18929
  Complete submission text file 0001415889-24-030001.txt   20382
Mailing Address 611 GATEWAY BOULEVARD, SUITE 740 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BOULEVARD, SUITE 740 SOUTH SAN FRANCISCO CA 94080 (415) 655-4168
SPRUCE BIOSCIENCES, INC. (Issuer) CIK: 0001683553 (see all company filings)

EIN.: 812154263 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 2001 JUNIPERO SERRA BOULEVARD, SUITE 640 DALY CITY CA 94104
Business Address
Charlton Ralph William III (Reporting) CIK: 0001919397 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39594 | Film No.: 241569459